Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial
PLOS Medicine · 2024
DOI: 10.1371/journal.pmed.1004393 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS Medicine, 2024. Verfasst von L Telisinghe und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. Hauptthemen laut MEDLINE: HIV Infections, Tuberculosis, Mass Screening. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH, PEPFAR.
Abstract (Originalsprache)
Background
HIV is a potent risk factor for tuberculosis (TB). Therefore, community-wide universal testing and treatment for HIV (UTT) could contribute to TB control, but evidence for this is limited. Community-wide TB screening can decrease population-level TB prevalence. Combining UTT with TB screening could therefore significantly impact TB control in sub-Saharan Africa, but to our knowledge there is no evidence for this combined approach. Methods and findings HPTN 071 (PopART) was a community-randomised trial conducted between November 2013 to July 2018; 21 Zambian and South African communities (with a total population of approximately 1 million individuals) were randomised to arms A (community-wide UTT and TB screening), B (community-wide universal HIV testing with treatment following national guidelines and TB screening), or C (standard-of-care). In a cohort of randomly selected adults (18 to 44 years) enrolled between 2013 and 2015 from all 21 communities (total size 38,474; 27,139 [71%] female; 8,004 [21%] HIV positive) and followed-up annually for 36 months to measure the population-level impact of the interventions, data on self-reported TB treatment in the previous 12 months (self-reported TB) were collected by trained research assistants and recorded using a structured questionnaire at each study visit. In this prespecified analysis of the trial, self-reported TB incidence rates were measured by calendar year between 2014 and 2017/2018. A p -value ≤0.05 on hypothesis testing was defined as reaching statistical significance. Between January 2014 and July 2018, 38,287 individuals were followed-up: 494 self-reported TB during 104,877 person-years. Overall incidence rates were similar across all arms in 2014 and 2015 (0.33 to 0.46/100 person-years). In 2016 incidence rates were lower in arm A compared to C overall (adjusted rate ratio [aRR] 0.48 [95% confidence interval (95% CI) 0.28 to 0.81; p = 0.01]), with statistical significance reached. In 2017/2018, while incidence rates were lower in arm A compared to C, statistical significance was not reached (aRR 0.58 [95% CI 0.27 to 1.22; p = 0.13]). Among people living with HIV (PLHIV) incidence rates were lower in arm A compared to C in 2016 (RR 0.56 [95% CI 0.29 to 1.08; p = 0.08]) and 2017/2018 (RR 0.50 [95% CI 0.26 to 0.95; p = 0.04]); statistical significance was only reached in 2017/2018. Incidence rates in arms B and C were similar, overall and among PLHIV. Among HIV–negative individuals, there were too few events for cross-arm comparisons. Study limitations include the use of self-report which may have been subject to under-reporting, limited covariate adjustment due to the small number of events, and high losses to follow-up over time.
Conclusions
In this study, community-wide UTT and TB screening resulted in substantially lower TB incidence among PLHIV at population-level, compared to standard-of-care, with statistical significance reached in the final study year. There was also some evidence this translated to a decrease in self-reported TB incidence overall in the population. Reduction in arm A but not B suggests UTT drove the observed effect. Our data support the role of UTT in TB control, in addition to HIV control, in high TB/HIV burden settings.
Trial registration
ClinicalTrials.gov: NCT01900977 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Zambart, Lusaka, Zambia.
- Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- The Desmond Tutu Tuberculosis Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
- Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
- The Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
ORCID-Profile: L Telisinghe, D MacLeod, R Dunbar, E Piwowar-Manning, K Shaunaube, P Bock, R J Hayes, H M Ayles
Förderung
- NIAID NIH HHS
- NIH
- PEPFAR
- International Initiative for Impact Evaluation
- Bill and Melinda Gates Foundation
- NIAID
- National Institute on Drug Abuse
- National Institute of Mental Health
Zitieren
APA
Telisinghe, L., Floyd, S., MacLeod, D., Schaap, A., Dunbar, R., Bwalya, J., Bell-Mandla, N., Piwowar-Manning, E., Donnell, D., Shaunaube, K., Bock, P., Fidler, S., Hayes, R. J., Ayles, H. M., & HPTN 071 (PopART) study team (2024). Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1004393
Vancouver
Telisinghe L, Floyd S, MacLeod D, Schaap A, Dunbar R, Bwalya J, et al. Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial. PLOS Medicine. 2024. doi:10.1371/journal.pmed.1004393
BibTeX
@article{Telisinghe2024,
author = {Telisinghe, L and Floyd, S and MacLeod, D and Schaap, A and Dunbar, R and Bwalya, J and Bell-Mandla, N and Piwowar-Manning, E and Donnell, D and Shaunaube, K and Bock, P and Fidler, S and Hayes, R J and Ayles, H M and HPTN 071 (PopART) study team, HPTN 071 (PopART) study team},
title = {Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial},
journal = {PLOS Medicine},
year = {2024},
doi = {10.1371/journal.pmed.1004393}
}
EUVIMED